Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
1998 1
2000 1
2003 3
2005 4
2006 3
2007 4
2008 6
2009 4
2010 4
2011 2
2012 5
2013 8
2014 7
2015 5
2016 2
2017 1
2018 3
2019 6
2020 7
2021 7
2022 7
2023 6
2024 11
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study.
Linton KM, Vitolo U, Jurczak W, Lugtenburg PJ, Gyan E, Sureda A, Christensen JH, Hess B, Tilly H, Cordoba R, Lewis DJ, Okada C, Hutchings M, Clausen MR, Sancho JM, Cochrane T, Leppä S, Chamuleau MED, Gernhardt D, Altıntaş I, Liu Y, Ahmadi T, Dinh MH, Hoehn D, Favaro E, Elliott B, Thieblemont C, Vose JM. Linton KM, et al. Among authors: favaro e. Lancet Haematol. 2024 Aug;11(8):e593-e605. doi: 10.1016/S2352-3026(24)00166-2. Epub 2024 Jun 15. Lancet Haematol. 2024. PMID: 38889737 Clinical Trial.
Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B-cell lymphoma.
Izutsu K, Kumode T, Yuda J, Nagai H, Mishima Y, Suehiro Y, Yamamoto K, Fujisaki T, Ishitsuka K, Ishizawa K, Ikezoe T, Nishikori M, Akahane D, Fujita J, Dinh M, Soong D, Noguchi H, Buchbjerg JK, Favaro E, Fukuhara N. Izutsu K, et al. Among authors: favaro e. Cancer Sci. 2023 Dec;114(12):4643-4653. doi: 10.1111/cas.15996. Epub 2023 Nov 3. Cancer Sci. 2023. PMID: 37921363 Free PMC article.
Indirect comparison of epcoritamab vs chemoimmunotherapy, mosunetuzumab, or odronextamab in follicular lymphoma.
Danilov AV, Kambhampati Thiruvengadam S, Linton K, Cumings K, Chirikov V, Mutebi A, Bains Chawla S, Chhibber A, Rivas Navarro F, Marques Gonçalves F, Wang A, Ding Z, Alshreef A, Favaro E, Hoehn D, Sureda A. Danilov AV, et al. Among authors: favaro e. Blood Adv. 2025 Aug 12;9(15):3754-3765. doi: 10.1182/bloodadvances.2024015274. Blood Adv. 2025. PMID: 40472301 Free PMC article. Clinical Trial.
Efficacy and safety of epcoritamab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma: 3-year follow-up from the EPCORE NHL-3 trial.
Izutsu K, Kumode T, Yuda J, Nagai H, Mishima Y, Suehiro Y, Yamamoto K, Fujisaki T, Ishitsuka K, Ishizawa K, Ikezoe T, Nishikori M, Akahane D, Fujita J, Jafarinasabian P, Soong D, D'Angelo Månsson B, Takahashi A, Favaro E, Fukuhara N. Izutsu K, et al. Among authors: favaro e. Int J Clin Oncol. 2025 Aug;30(8):1631-1640. doi: 10.1007/s10147-025-02788-0. Epub 2025 May 28. Int J Clin Oncol. 2025. PMID: 40434509 Free PMC article. Clinical Trial.
Glycogen metabolism in cancer.
Zois CE, Favaro E, Harris AL. Zois CE, et al. Among authors: favaro e. Biochem Pharmacol. 2014 Nov 1;92(1):3-11. doi: 10.1016/j.bcp.2014.09.001. Epub 2014 Sep 16. Biochem Pharmacol. 2014. PMID: 25219323 Review.
Subcutaneous epcoritamab monotherapy in Japanese patients with relapsed or refractory follicular lymphoma: primary results of the EPCORE NHL-3 trial.
Izutsu K, Akahane D, Toubai T, Saito T, Mishima Y, Fujisaki T, Nishikori M, Kumode T, Suehiro Y, Ishitsuka K, Conlon R, Takahashi A, D'Angelo Månsson B, Favaro E, Fukuhara N. Izutsu K, et al. Among authors: favaro e. Leuk Lymphoma. 2025 Oct;66(10):1913-1921. doi: 10.1080/10428194.2025.2525983. Epub 2025 Jul 9. Leuk Lymphoma. 2025. PMID: 40632620 Free article. Clinical Trial.
Role of extracellular vesicles in stem cell biology.
Bruno S, Chiabotto G, Favaro E, Deregibus MC, Camussi G. Bruno S, et al. Among authors: favaro e. Am J Physiol Cell Physiol. 2019 Aug 1;317(2):C303-C313. doi: 10.1152/ajpcell.00129.2019. Epub 2019 May 15. Am J Physiol Cell Physiol. 2019. PMID: 31091143 Free PMC article. Review.
Association between Chronic Kidney Disease-Mineral and Bone Disorder Biomarkers and Symptom Burden in Older Patients with Advanced Chronic Kidney Disease: Results from the EQUAL Study.
Magagnoli L, Cozzolino M, Evans M, Caskey FJ, Dekker FW, Torino C, Szymczak M, Drechsler C, Pippias M, Vilasi A, Janse RJ, Krajewska M, Stel VS, Jager KJ, Chesnaye NC; EQUAL study investigators. Magagnoli L, et al. Clin J Am Soc Nephrol. 2024 Oct 1;19(10):1240-1252. doi: 10.2215/CJN.0000000000000510. Epub 2024 Jul 22. Clin J Am Soc Nephrol. 2024. PMID: 39037951 Free PMC article.
RNA interference: implications for cancer treatment.
Masiero M, Nardo G, Indraccolo S, Favaro E. Masiero M, et al. Among authors: favaro e. Mol Aspects Med. 2007 Feb;28(1):143-66. doi: 10.1016/j.mam.2006.12.004. Epub 2007 Jan 11. Mol Aspects Med. 2007. PMID: 17307250 Review.
107 results